BRIEF published on 04/30/2024 at 18:05, 1 year 10 months ago Breakthrough in Treatment for Macular Degeneration Blindness by Mesogen Inc. Biotechnology Healthcare Innovation Mesogen Inc Macular Degeneration Stem Cell Treatment
PRESS RELEASE published on 04/30/2024 at 18:00, 1 year 10 months ago Texas Company's Mission to Cure Macular Degeneration Blindness Mesogen Inc. from The Woodlands, Texas, developed a transplantable RPE patch for Macular Degeneration Blindness using autologous stem cells with no teratoma tumor risk Stem Cells Treatment Mesogen Inc. Macular Degeneration Blindness RPE Patch
Published on 03/26/2026 at 13:00, 1 hour 38 minutes ago Prospect Ridge Strengthens Technical Team with Appointment of Phil Smerchanski as Senior Technical Advisor
Published on 03/26/2026 at 13:00, 1 hour 38 minutes ago GameSquare's Stream Hatchet Launches Creator Communities to Manage the Full Creator Marketing Lifecycle
Published on 03/26/2026 at 12:59, 1 hour 39 minutes ago Adcore Concludes Fiscal Year 2025 With Strong Q4 Performance
Published on 03/26/2026 at 12:45, 1 hour 53 minutes ago Quartz Mountain Reports Strong Warrant Exercise Participation and Provides Exploration Update at Maestro Project, Central British Columbia
Published on 03/26/2026 at 14:20, 18 minutes ago Hotel Sacher Vienna celebrates its 150th anniversary - with sculptures by Erwin Wurm
Published on 03/26/2026 at 14:18, 20 minutes ago RHÖN-KLINIKUM AG with consistent development in financial year 2025
Published on 03/26/2026 at 07:30, 7 hours 8 minutes ago BIOPHYTIS-LYNXKITE ALLIANCE INVITED TO NVIDIA CONFERENCE: UNLEASHING AI TO REVOLUTIONIZE LONGEVITY
Published on 03/25/2026 at 18:31, 20 hours 7 minutes ago Strong investment performance and active roll-out of our strategy
Published on 03/25/2026 at 17:45, 20 hours 53 minutes ago Combined General Meeting on May 05, 2026: publication of the notice of Meeting
